These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38238479)

  • 1. Modelling the impact of sublingual immunotherapy versus subcutaneous immunotherapy on patient travel time and CO
    Cardell LO; Sterner T; Ahmed W; Slættanes AK; Svärd M; Pollock RF
    Sci Rep; 2024 Jan; 14(1):1575. PubMed ID: 38238479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-minimization analysis of sublingual immunotherapy versus subcutaneous immunotherapy for house dust mite respiratory allergic disease in Denmark.
    Rønborg S; Johnsen CR; Theilgaard S; Winther A; Hahn-Pedersen J; Andreasen JN; Olsen J
    J Med Econ; 2016 Aug; 19(8):735-41. PubMed ID: 26909663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Cost-Minimisation Analysis Comparing Sublingual Immunotherapy to Subcutaneous Immunotherapy for the Treatment of House Dust Mite Allergy in a Swedish Setting.
    Björstad Å; Cardell LO; Hahn-Pedersen J; Svärd M
    Clin Drug Investig; 2017 Jun; 37(6):541-549. PubMed ID: 28326466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
    Calderon MA; Casale TB; Nelson HS; Demoly P
    J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient preferences for route of allergy immunotherapy: a comparison of four delivery methods.
    Chester JG; Bremberg MG; Reisacher WR
    Int Forum Allergy Rhinol; 2016 May; 6(5):454-9. PubMed ID: 26833457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto- Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Respiratory Society (DGP), the German Association of ENT Surgeons (BV-HNO), the Professional Federation of Paediatricians and Youth Doctors (BVKJ), the Federal Association of Pulmonologists (BDP) and the German Dermatologists Association (BVDD).
    Pfaar O; Bachert C; Bufe A; Buhl R; Ebner C; Eng P; Friedrichs F; Fuchs T; Hamelmann E; Hartwig-Bade D; Hering T; Huttegger I; Jung K; Klimek L; Kopp MV; Merk H; Rabe U; Saloga J; Schmid-Grendelmeier P; Schuster A; Schwerk N; Sitter H; Umpfenbach U; Wedi B; Wöhrl S; Worm M; Kleine-Tebbe J; Kaul S; Schwalfenberg A
    Allergo J Int; 2014; 23(8):282-319. PubMed ID: 26120539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefit of SLIT and SCIT for Allergic Rhinitis and Asthma.
    Passalacqua G; Canonica GW; Bagnasco D
    Curr Allergy Asthma Rep; 2016 Nov; 16(12):88. PubMed ID: 27957697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world, long-term effectiveness of allergy immunotherapy in allergic rhinitis: Subgroup analyses of the REACT study.
    Contoli M; Porsbjerg C; Buchs S; Larsen JR; Freemantle N; Fritzsching B
    J Allergy Clin Immunol; 2023 Aug; 152(2):445-452.e4. PubMed ID: 36871918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of sublingual versus subcutaneous immunotherapy in children with allergic rhinitis: a systematic review and meta-analysis.
    Yang J; Lei S
    Front Immunol; 2023; 14():1274241. PubMed ID: 38162647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shifts in allergy practice in a COVID-19 world: Implications of pre-COVID-19 national health care provider and patient surveys of treatments for nasal allergies.
    Winders T; DuBuske L; Bukstein DA; Meltzer EO; Wallace D; Rance K
    Allergy Asthma Proc; 2021 Jul; 42(4):301-309. PubMed ID: 34030767
    [No Abstract]   [Full Text] [Related]  

  • 11. State of the Art: Development of a Sublingual Allergy Immunotherapy Tablet for Allergic Rhinitis in Japan.
    Ohashi-Doi K; Lund K; Mitobe Y; Okamiya K
    Biol Pharm Bull; 2020; 43(1):41-48. PubMed ID: 31902930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Subcutaneous and Sublingual Immunotherapy for House Dust Mite Allergy: A Network Meta-Analysis-Based Comparison.
    Kim JY; Jang MJ; Kim DY; Park SW; Han DH
    J Allergy Clin Immunol Pract; 2021 Dec; 9(12):4450-4458.e6. PubMed ID: 34464748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of grass pollen subcutaneous immunotherapy (SCIT) compared to sublingual immunotherapy (SLIT) and symptomatic treatment in Austria, Spain, and Switzerland.
    Brüggenjürgen B; Reinhold T
    J Med Econ; 2018 Apr; 21(4):374-381. PubMed ID: 29271271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network meta-analysis shows commercialized subcutaneous and sublingual grass products have comparable efficacy.
    Nelson H; Cartier S; Allen-Ramey F; Lawton S; Calderon MA
    J Allergy Clin Immunol Pract; 2015; 3(2):256-266.e3. PubMed ID: 25609326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compliance, efficacy, and safety of subcutaneous and sublingual immunotherapy in children with allergic rhinitis.
    Liu W; Zeng Q; He C; Chen R; Tang Y; Yan S; Luo X; Luo R
    Pediatr Allergy Immunol; 2021 Jan; 32(1):86-91. PubMed ID: 32810884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of grass pollen allergen immunotherapy in adults.
    Di Bona D; Bilancia M; Albanesi M; Caiaffa MF; Macchia L
    Allergy; 2020 Sep; 75(9):2319-2329. PubMed ID: 32096242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing the compliance to a short schedule of subcutaneous immunotherapy and to sublingual immunotherapy during three years of treatment.
    Manzotti G; Riario-Sforza GG; Dimatteo M; Scolari C; Makri E; Incorvaia C
    Eur Ann Allergy Clin Immunol; 2016 Nov; 48(6):224-227. PubMed ID: 27852426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term health care resource and cost savings with allergy immunotherapy: REACT study results.
    Fritzsching B; Porsbjerg C; Contoli M; Buchs S; Larsen JR; Freemantle N
    J Allergy Clin Immunol Glob; 2024 Feb; 3(1):100197. PubMed ID: 38226187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous Versus Sublingual Immunotherapy for Adults with Allergic Rhinitis: A Systematic Review with Meta-Analyses.
    Tie K; Miller C; Zanation AM; Ebert CS
    Laryngoscope; 2022 Mar; 132(3):499-508. PubMed ID: 33929726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grass pollen sublingual immunotherapy tablets provide long-term relief of grass pollen-associated allergic rhinitis and reduce the risk of asthma: findings from a retrospective, real-world database subanalysis.
    Devillier P; Wahn U; Zielen S; Heinrich J
    Expert Rev Clin Immunol; 2017 Dec; 13(12):1199-1206. PubMed ID: 29072507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.